Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorPINTAT, J.
dc.contributor.authorSILVESTRE, A.
dc.contributor.authorMAGALON, G.
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorGADEAU, Alain-Pierre
dc.contributor.authorPESQUER, L.
dc.contributor.authorPEROZZIELLO, A.
dc.contributor.authorPEUCHANT, A.
dc.contributor.authorMOUNAYER, C.
dc.contributor.authorDALLAUDIÈRE, B.
dc.date.accessioned2020
dc.date.available2020
dc.date.issued2017
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/21221
dc.description.abstractEnPURPOSE: To assess the feasibility and safety of concomitant intra-articular (IA) knee injection of mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) under fluoroscopic guidance to treat patellofemoral osteoarthritis (OA). MATERIALS AND METHODS: This prospective study included 19 consecutive patients referred for fluoroscopically guided IA MSC and PRP injection for symptomatic patellofemoral chondropathy in which conservative treatment had failed. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score and magnetic resonance (MR) data, including T2 mapping sequence, were prospectively collected before and 6 months after treatment. Clinical data without MR imaging were collected until 12 months after the procedure. RESULTS: WOMAC scores were significantly lower after IA injection of MSCs and PRP at 6 months and during 12-months follow-up compared with baseline (mean score decreased from 34.3 to 14.2; P \textless .0018). Patients reported no complications. Concerning MR imaging follow-up, there were no significant differences in grade, surface, or T2 value of the chondral lesions (P \textgreater .375). CONCLUSIONS: IA injection of MSCs and PRP in early patellofemoral OA appears to allow functional improvement. Copyright © 2017 SIR. Published by Elsevier Inc. All rights reserved.
dc.language.isoENen_US
dc.subject*Article RECHERCHE
dc.title.enIntra-articular Injection of Mesenchymal Stem Cells and Platelet-Rich Plasma to Treat Patellofemoral Osteoarthritis: Preliminary Results of a Long-Term Pilot Study.
dc.title.alternativeJ Vasc Interv Radiolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jvir.2017.08.004en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologieen_US
bordeaux.journalJ Vasc Interv Radiolen_US
bordeaux.page1708–1713en_US
bordeaux.volume28en_US
bordeaux.hal.laboratoriesBiologie des maladies cardiovasculaires - U1034en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=J%20Vasc%20Interv%20Radiol&rft.date=2017&rft.volume=28&rft.spage=1708%E2%80%931713&rft.epage=1708%E2%80%931713&rft.au=PINTAT,%20J.&SILVESTRE,%20A.&MAGALON,%20G.&GADEAU,%20Alain-Pierre&PESQUER,%20L.&rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record